Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manoranjenni Chetty

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Clinical Neuropharmacology|March 30, 2005
Psychotropic drug interactions with valproateJessica Fleming, Manoranjenni Chetty
Current Drug Metabolism|May 17, 2007
CYP-mediated clozapine interactions: how predictable are they?Manoranjenni Chetty, Michael Murray
Clinical Neuropharmacology|December 20, 2007
Dosing and therapeutic monitoring of phenytoin in young adults after neurotrauma: are current practices relevant?Vivien Frend, Manoranjenni Chetty
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 18, 2008
Differential pharmacological regulation of drug efflux and pharmacoresistant schizophreniaMary Bebawy, Manoranjenni Chetty
Clinical Neuropharmacology|November 11, 2006
Therapeutic monitoring of valproate in psychiatry: how far have we progressed?Jessica Fleming, Manoranjenni Chetty
Current Drug Metabolism|November 30, 2018
Progress in the Consideration of Possible Sex Differences in Drug Interaction StudiesPanjasaram Naidoo, Manoranjenni Chetty
Clinical and Translational Science|May 31, 2021
Potential benefit of vitamin D supplementation in people with respiratory illnesses, during the COVID-19 pandemicVasudevan V Chetty, Manoranjenni Chetty
Clinical Pharmacology and Therapeutics|September 24, 2020
Clopidogrel Dosing: Current Successes and Emerging Factors for Further ConsiderationManoranjenni Chetty, Paulien Ravenstijn, Pooja Manchandani
Drugs in R&D|October 12, 2019
Are Standard Doses of Renally-Excreted Antiretrovirals in Older Patients Appropriate: A PBPK Study Comparing Exposures in the Elderly Population With Those in Renal ImpairmentM De Sousa Mendes, Manoranjenni Chetty
Clinical and Translational Science|May 13, 2021
Design and conduct considerations for studies in patients with impaired renal functionPaulien Ravenstijn, Manoranjenni Chetty, Pooja Manchandani
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Clinical Neuropharmacology|March 30, 2005
Psychotropic drug interactions with valproateJessica Fleming, Manoranjenni Chetty
Current Drug Metabolism|May 17, 2007
CYP-mediated clozapine interactions: how predictable are they?Manoranjenni Chetty, Michael Murray
Clinical Neuropharmacology|December 20, 2007
Dosing and therapeutic monitoring of phenytoin in young adults after neurotrauma: are current practices relevant?Vivien Frend, Manoranjenni Chetty
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|January 18, 2008
Differential pharmacological regulation of drug efflux and pharmacoresistant schizophreniaMary Bebawy, Manoranjenni Chetty
Clinical Neuropharmacology|November 11, 2006
Therapeutic monitoring of valproate in psychiatry: how far have we progressed?Jessica Fleming, Manoranjenni Chetty
Current Drug Metabolism|November 30, 2018
Progress in the Consideration of Possible Sex Differences in Drug Interaction StudiesPanjasaram Naidoo, Manoranjenni Chetty
Clinical and Translational Science|May 31, 2021
Potential benefit of vitamin D supplementation in people with respiratory illnesses, during the COVID-19 pandemicVasudevan V Chetty, Manoranjenni Chetty
Clinical Pharmacology and Therapeutics|September 24, 2020
Clopidogrel Dosing: Current Successes and Emerging Factors for Further ConsiderationManoranjenni Chetty, Paulien Ravenstijn, Pooja Manchandani
Drugs in R&D|October 12, 2019
Are Standard Doses of Renally-Excreted Antiretrovirals in Older Patients Appropriate: A PBPK Study Comparing Exposures in the Elderly Population With Those in Renal ImpairmentM De Sousa Mendes, Manoranjenni Chetty
Clinical and Translational Science|May 13, 2021
Design and conduct considerations for studies in patients with impaired renal functionPaulien Ravenstijn, Manoranjenni Chetty, Pooja Manchandani
Pageof 3